Intriguingly, IHC revealed significantly lower expression of PCYT2 in live metastatic tumor compared with primary tumor (Figure 1G), implying the possible involvement of PCYT2 in CRC liver metastasis. This evidence concerns the gene PCYT2 and metastatic neoplasm.